{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:16:20Z","timestamp":1786979780789,"version":"build-2736575974"},"reference-count":31,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DHPS"],"DOI":"10.2147\/dhps.s311817","type":"journal-article","created":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T20:46:05Z","timestamp":1622061965000},"page":"117-123","source":"Crossref","is-referenced-by-count":5,"title":["Ophthalmic Solution Safety Profile: Active Surveillance of a Sodium Hyaluronate\/Chondroitin Sulfate Combination in Peruvian Population"],"prefix":"10.2147","volume":"Volume 13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9918-2024","authenticated-orcid":true,"given":"Homero","family":"Contreras-Salinas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Barajas-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leopoldo Mart\u00edn","family":"Baiza-Dur\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Orozco-Ceja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes Yolotzin","family":"Rodr\u00edguez-Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,5]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","volume":"15","author":"Bron","year":"2017","journal-title":"Ocul Surf"},{"key":"ref2","first-page":"1","volume":"2015","author":"Phadatare","year":"2015","journal-title":"Adv Pharm"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/01.OPX.0000156310.45736.FA","volume":"82","author":"Hom","year":"2005","journal-title":"Optom Vis Sci"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"520","DOI":"10.21149\/9024","volume":"60","author":"Graue-Hern\u00e1ndez","year":"2018","journal-title":"Salud Publica Mex"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jtos.2017.05.006","volume":"15","author":"Jones","year":"2017","journal-title":"Ocul Surf"},{"key":"ref6","first-page":"86","volume":"82","author":"Duran","year":"2008","journal-title":"Rev Mex Oftalmol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/02713683.2020.1849733","author":"Belalc\u00e1zar-Rey","year":"2020","journal-title":"Curr Eye Res"},{"key":"ref8","volume-title":"Ocular Pharmacokinetics BT - Pharmacologic Therapy of Ocular Disease","year":"2017"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1016\/j.clinthera.2018.07.012","volume":"40","author":"Beninger","year":"2018","journal-title":"Clin Ther"},{"key":"ref10","first-page":"36","volume":"3","author":"Garotta","year":"1991","journal-title":"J Chemother"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"143","DOI":"10.4081\/reumatismo.2013.143","volume":"65","author":"Varenna","year":"2013","journal-title":"Reumatismo"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00228-018-2455-z","volume":"74","author":"Li","year":"2018","journal-title":"Eur J Clin Pharmacol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s40264-016-0432-y","volume":"39","author":"Mann","year":"2016","journal-title":"Drug Saf"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1089\/pop.2012.0100","volume":"16","author":"Moses","year":"2013","journal-title":"Popul Health Manag"},{"key":"ref15","unstructured":"ICH harmonized tripartite guideline. Pharmacovigilance planning; November 18, 2004. Available from: https:\/\/database.ich.org\/sites\/default\/files\/E2E_Guideline.pdf. Accessed May 11, 2021."},{"key":"ref16","unstructured":"Council for International Organization of Medical Sciences (CIOMS). Working Group IV Benefit-Risk Balance for Marketed Drugs: Evaluating Safety Signals. 1st ed. 1998."},{"key":"ref17","first-page":"2229","volume":"49","author":"Hartwig","year":"1992","journal-title":"Am J Hosp Pharm"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1600-0420.1996.tb00086.x","volume":"74","author":"Marner","year":"1996","journal-title":"Acta Ophthalmol Scand"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1177\/112067210701700202","volume":"17","author":"Wang","year":"2007","journal-title":"Eur J Ophthalmol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"CD009729","DOI":"10.1002\/14651858.CD009729.pub2","volume":"2","author":"Pucker","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s00228-008-0494-6","volume":"64","author":"Zopf","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.clae.2018.12.003","volume":"42","author":"Lievens","year":"2019","journal-title":"Cont Lens Anterior Eye"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jtos.2017.05.002","volume":"15","author":"Belmonte","year":"2017","journal-title":"Ocul Surf"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/j.1600-0420.1997.tb00413.x","volume":"75","author":"Brodwall","year":"1997","journal-title":"Acta Ophthalmol Scand"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"665","DOI":"10.2147\/OPTH.S78184","volume":"9","author":"Simmons","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"3305","DOI":"10.1016\/S0142-9612(01)00167-3","volume":"22","author":"Nepp","year":"2001","journal-title":"Biomaterials"},{"key":"ref28","first-page":"295","volume":"58","author":"Hill","year":"1965","journal-title":"Proc R Soc Med"},{"key":"ref29","unstructured":"Sodium hyaluronate. Micromedex; 2020. Available from: https:\/\/www.micromedexsolutions.com\/. Accessed September 25, 2020."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1136\/bjo.2007.121533","volume":"92","author":"Mochizuki","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"ref31","first-page":"497","volume":"101","author":"Hughes","year":"1983","journal-title":"Arch Ophthalmol"}],"container-title":["Drug, Healthcare and Patient Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=69893","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=69893","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T20:46:18Z","timestamp":1622061978000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/ophthalmic-solution-safety-profile-active-surveillance-of-a-sodium-hya-peer-reviewed-fulltext-article-DHPS"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":31,"URL":"https:\/\/doi.org\/10.2147\/dhps.s311817","relation":{},"ISSN":["1179-1365"],"issn-type":[{"value":"1179-1365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5]]}}}